US green light for homegrown drug Zaynich marks rare leap for Indian pharmaceutical company from generic medicines to ...
Lancet Microbe's ESCMID 2026 coverage highlights global Phase III Integral-2 results for novel β-lactamase inhibitor ...
Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced the U.S. Food and Drug ...
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam ...
A combination of cannabidiol (CBD) and the anti-inflammatory drug diclofenac killed certain types of bacteria more effectively than either compound alone, according to a new study published in the ...
A metabolic byproduct formed when gut bacteria break down dietary fiber appears to protect against dangerous fungal ...
Anatomical factors and device integration require modified diagnostic workflows to manage complicated urinary tract ...
Fast identification of bacteria is important in health care, food safety, environmental monitoring and infection control. One ...
The beauty company Kao USA recalled its shampoo after detecting a potentially harmful bacteria. The shampoo was sold in ...
The beauty company Kao USA recalled its shampoo after detecting a potentially harmful bacteria. The shampoo was sold in ...
Researchers from Skoltech and other science centers in Russia have developed a reporter system—a tool for screening potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results